Issue published 30 December 2025 Abstract Background: To determine whether initiating a glucagon-like peptide-1 receptor agonist (GLP-1 RA) within 3 months of type 2 diabetes (T2DM) diagnosis alters the subsequent risk of overall and site-specific cancer and whether this association differs by baseline body-mass index (BMI)
Is weight loss a side effect of Wellbutrin
engle, d., belisle, j., gubbels, j., petrie, s., hutson, p., kushner, d., & patankar, m
When you are eating less food overall, every meal needs to count
Persistent injection site lumps (lipodystrophy from poor rotation)
One-on-one lifestyle coaches for behavior change and motivation, mindful eating and nutrition coaching with sample meal plans, and a nutrition reportplus fitness education